Diphenhydramine Facts
Deliriant;
Description
Diphenhydramine is a synthetic depressant and deliriant of the ethanolamine antihistamine class. It blocks histamine and acetylcholine signaling in the brain, producing sedation at low doses and full delirium at high ones.
Subjective effects include sedation, dry mouth, impaired coordination, and — at high doses — vivid hallucinations, disorientation, and memory blackout. The high-dose experience is defined by a complete loss of reality testing — hallucinations feel indistinguishable from real life, and the state is overwhelmingly dysphoric.
Diphenhydramine produces both physical and psychological dependence with chronic use,[1] and the margin between a therapeutic and a fatal dose is narrow.[2][3] Tolerance to sedation drives dose escalation; overdose disrupts heart rhythm through two independent mechanisms,[4] and chronic use is linked to higher dementia risk.[5]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 4 – 8 hoursAfter-effects 6 – 12 hours
Body and dependence
- Acute toxicity
- High
- Chronic toxicity
- High
- Physical dependence
- Moderate
- Psychological dependence
- Moderate
- Withdrawal
- Mild
- Compulsive redosing
- Low
Tolerance
- Builds
- Rapid
- Fully resets after
- Not recorded
Effectslikely at a common dose
- Perception
- Sleep-transition hallucinations;
+15 possible, including Visual acuity suppression, Visual haze / noise, Spatial disorientation - Body
- Physical fatigue;
Sedation; Dry mouth; Pupil dilation; +16 possible, including Motor control impairment, Dehydration sensation, Dizziness - Thinking
- Focus suppression;
Cognitive impairment; +18 possible, including Analysis suppression, Memory suppression, Cognitive dysphoria - Feeling
- none likely · 9 possible, including Dysphoria, Anxiety, Emotional lability
- Self
- none likely · 7 possible, including Communication suppression, Social disconnection, Derealization
- Time
- none likely · 2 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Deliriants are genuinely dangerous — treat any strong reaction as a medical emergency.
- True delirium — confused, disoriented, doesn't know what's real or recognize people/danger
- Vivid, frightening hallucinations; agitation or aggression
- Hot, flushed, dry skin and high body temperature
- Dilated pupils; blurred vision
- Fast heartbeat; inability to urinate
- Seizures; unconsciousness
What to do
- Call emergency services — deliriant poisoning (especially datura / belladonna) can be life-threatening
- Keep them physically safe — they may not know what they're doing and can badly injure themselves; remove hazards and stay with them
- Do not leave them alone; do not try to reason them out of it — they are delirious
- If overheating, cool the body
- Recovery position if drowsy, vomiting, or unconscious; be ready for rescue breaths / CPR
Deliriant effects are long (many hours to more than a day) and the person is not safe or in control throughout. The main dangers are self-injury during delirium, overheating, and — for potent anticholinergics like datura — cardiac and central-nervous-system toxicity. Medical monitoring is often needed.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Erbe S, Bschor T (2013) [Diphenhydramine addiction and detoxification. A systematic review and case report]. — Psychiatrische Praxis doi:10.1055/s-0032-1332949
- [2]
- [3]^Macorano E, Tarozzi I, Gitto L (2026) Death due to diphenhydramine toxicity: A 9-year review from the Cook County Medical Examiner's Office and a review of the literature. — Journal of Forensic Sciences doi:10.1111/1556-4029.70239
- [4]^Carroll S, McGee M, Audette M, Tuttle M, Corcoran J, Stanton M, Feldman R (2026) Lidocaine for diphenhydramine-induced ventricular tachycardia: A case report. — The American Journal of Emergency Medicine doi:10.1016/j.ajem.2026.01.040
- [5]^Zhu N, Eriksdotter M, Liabeuf S, Tan ECK, Johnell K, Garcia-Ptacek S, Xu H (2025) Anticholinergic burden and incident dementia: a Swedish nationwide case-control study. — Alzheimer's Research & Therapy doi:10.1186/s13195-025-01883-8